Stockscreener 앱 받기
9.91
2.59%
0.25
시간 외 거래:
9.96
0.05
+0.50%
Immunome Inc 주식(IMNM)의 최신 뉴스
When is the best time to exit Immunome Inc.Weekly Price Target Forecast and Alerts - Newser
Chart based analysis of Immunome Inc. trendsPortfolio Positioning Strategy With Timing - Newser
What makes Immunome Inc. stock attractive to long term investorsDaily Pattern Analysis with Return Forecast - Newser
Will Immunome Inc. stock recover after recent dropFree Fundamental Winners With Safe Entry Plan - Newser
Immunome's Undervalued Gamma Secretase Inhibitor Pipeline in Light of SpringWorks' Merck Acquisition - AInvest
Immunome's SpringWorks Buyout Highlights Upside Potential - AInvest
Immunome: SpringWorks Buyout Informs The Potential Upside Here (NASDAQ:IMNM) - Seeking Alpha
What makes Immunome Inc. stock price move sharplyReal-Time AI Generated Market Forecast - Newser
Immunome Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Wedbush Comments on Immunome’s Q3 Earnings (NASDAQ:IMNM) - Defense World
Research Analysts Offer Predictions for Immunome Q3 Earnings - Defense World
What recovery options are there for Immunome Inc.5-Year Price Trend Summary and Analysis - Newser
How Immunome Inc. stock performs during market volatilityLong-Term Allocation Strategy Summary Breakdown - Newser
Is Immunome Inc. benefiting from innovation trendsSmart Portfolio Allocation - newsyoung.net
Will Immunome Inc. bounce back from current supportWeekly Price Target Forecast and Alerts - Newser
Immunome, Inc. (NASDAQ:IMNM) Revenue Estimates Upgraded by 73% - AInvest
Growth Investors: Industry Analysts Just Upgraded Their Immunome, Inc. (NASDAQ:IMNM) Revenue Forecasts By 73% - Yahoo Finance
How to forecast Immunome Inc. trends using time seriesDaily Trade Monitor with Pattern Alerts - Newser
Immunome, Inc. (NASDAQ:IMNM) Given Average Rating of “Buy” by Brokerages - Defense World
Immunome 2025 Q2 Earnings Wider Net Loss Despite Revenue Surge - AInvest
New Product Launches: Will They Boost Immunome Inc. Stock in 2025Growth Focused Entry Plan Suggestions Issued - beatles.ru
JP Morgan Lowers Price Target for Immunome (IMNM) While Maintain - GuruFocus
Immunome 2025 Q2 Earnings Narrowed EPS Loss, 69.8% Revenue Growth - AInvest
What’s next for Immunome Inc. stock priceFree Secure Return Focused Investment Plan - Newser
Immunome Reports Second Quarter 2025 Financial Results and Provides Business Update - BioSpace
Immunome Advances Cancer Therapy Pipeline Amid Financial Loss - TipRanks
Does Immunome Inc. qualify in momentum factor screeningFree Triple Return Setup with Risk Control - Newser
Immunome earnings beat by $0.12, revenue topped estimates - Investing.com Canada
Immunome’s Promising Clinical Progress and Strong Financial Position Justify Buy Rating - TipRanks
Immunome Q2 Earnings: Revenue $4.01M, Consensus $1.02M; Expects Cash to Fund Operations into 2027 - AInvest
Immunome, Inc. (IMNM) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Immunome Reports Second Quarter 2025 Financial Results and Provi - GuruFocus
Detecting price anomalies in Immunome Inc. with AIFree Weekly Potential Breakout Stock List - Newser
Can Immunome Inc. rally from current levelsStock Entry Point Planner with Volume Spike - Newser
Will Immunome Inc. continue its uptrendStock Market Trend and Pattern Analysis - Newser
What to do if you’re stuck in Immunome Inc.Real Stock Picks With Setup Verification - Newser
What earnings revisions data tells us about Immunome Inc.Trading Volume Spike and Reversal Analysis - Newser
What momentum shifts mean for Immunome Inc.Trade Flow Monitor with Volume Tracker - Newser
Will Immunome Inc. Stock Benefit from AI and Green Energy TrendsLow Risk High Confidence Watchlist Builder - Newser
What institutional investors are buying Immunome Inc. stockAchieve rapid portfolio growth with smart picks - Jammu Links News
How does Immunome Inc. compare to its industry peersCapitalize on stocks with high profit margins - Jammu Links News
What are Immunome Inc. company’s key revenue driversCapitalize on emerging industry trends - Jammu Links News
What is the risk reward ratio of investing in Immunome Inc. stockOutstanding capital returns - Jammu Links News
Is it the right time to buy Immunome Inc. stockInvest confidently with actionable market data - Jammu Links News
When is Immunome Inc. stock expected to show significant growthMaximize returns with effective portfolio management - Jammu Links News
Is Immunome Inc. stock overvalued or undervaluedRealize exceptional returns through smart trading - Jammu Links News
Immunome Inc. Stock Analysis and ForecastUnlock expert market analysis instantly - Jammu Links News
What is the dividend policy of Immunome Inc. stockBuild wealth faster with high-performing stocks - Jammu Links News
0.91%
3.06%
자본화:
|
볼륨(24시간):